Canadian public health officials said last week they plan to approve coronavirus vaccines along similar timelines to the U.S. and European countries.

What happens after you get your first COVID-19 shot? Initially, not much, experts say.

It comes days after the drugmaker announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

Preliminary results show CoronaVac triggered a quick immune response but level of antibodies were lower than in people who had recovered from the disease.

A final analysis of the Phase 3 trial of Pfizer's coronavirus vaccine shows it was 95 per cent effective in preventing infections.

With millions of doses of a wide range of potential coronavirus vaccine candidates secured, experts weigh in on who might get the shots first.

A new poll suggests the proportion of Canadians planning to get vaccinated for COVID-19 is on the rise after encouraging initial results from Pfizer's vaccine trial.

Pfizer's vaccine candidate was shown to be more than 90% effective in preventing COVID-19 based on initial data, but the company faces distribution and storage challenges.

We answer five key questions about the phase 3 trial results, roll out and storage, as US company says its coronavirus vaccine is nearly 95 per cent effective.

A week ago, competitor Pfizer Inc. announced its own COVID-19 vaccine appeared similarly effective.